InvestmentJul 10, 2026, 08:02 AM
Silo Pharma Raises $4M Upfront, Potential $7.7M from Warrants
AI Summary
Silo Pharma, Inc. announced definitive agreements for a private placement expected to generate approximately $4 million in gross proceeds. The offering includes common stock and warrants, with potential for an additional $7.7 million if the warrants are fully exercised. The company intends to use the net proceeds for working capital and general corporate purposes, supporting its developmental-stage biopharmaceutical programs.
Key Highlights
- Silo Pharma secured $4 million in gross proceeds from a private placement.
- Potential additional gross proceeds of approximately $7.7 million if warrants are fully exercised.
- The offering includes 619,965 shares of common stock (or pre-funded warrants) and Series A-3 and A-4 warrants.
- Purchase price per share (or pre-funded warrant) and associated warrants is $6.452.
- Warrants have an exercise price of $6.21 per share and are immediately exercisable.
- Net proceeds will be used for working capital and general corporate purposes.
Price Impact
More from SILO